Compare Repligen Corporation Common Stock (RGEN) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs United States Oil ETF — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B), while United States Oil ETF trades at $153.17 (market cap $1.86B). The key difference: Repligen Corporation Common Stock is far larger — about 6.1× United States Oil ETF's market cap, and United States Oil ETF is more actively traded (2,900,350 versus 1,216,919). Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and United States Oil ETF for 21 Days on average.
| RGEN | USO | |
|---|---|---|
Market Cap | $11.31B | $1.86B |
Volume | 1,216,919 | 2,900,350 |
Sector | Health | — |
52-Week High | $194.57 | $161.86 |
52-Week Low | $102.87 | $66.17 |
Typical Hold Time | 0 Days | 21 Days |
Enterprise Value | $11.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
USO is trading at $153.09, up 1.36% with a bullish technical outlook supported by strong moving average signals. Recent news highlights ongoing Middle East tensions affecting oil supply chains, with OPEC+ maintaining steady output targets while G-7 nations plan strategic fuel releases to curb prices. The stock shows positive momentum despite mixed oscillators and geopolitical uncertainties.
The outlook remains cautiously optimistic with technical strength offset by fundamental data gaps and geopolitical risks. Investment opportunity exists if supply disruptions persist, but volatility from political events and coordinated government interventions pose significant near-term risks for energy sector investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
